Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlmazov National Medical Research Centre

About this trial

The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.

Eligibility criteria

Qualifiers

Diagnosis of acute pancreatitis confirmed on the basis of at least 2 of the 3 diagnostic criteria according to the revised Atlanta classification

Presence of organ failure signs (moderate and severe pancreatitis)

Informed consent of the patient

Disqualifiers

Presence of other indications for endoscopic intervention on the major duodenal papilla (biliary pancreatitis with cholangitis, calculus of the major duodenal papilla, stenosis of the major duodenal papilla, etc.)

Previous surgical interventions on the major duodenal papilla

Diverticula of the major duodenal papilla

Pregnancy

Trial design

Treatments tested in this trial

  • Endoscopic pancreatic duct stent placement
  • Conventional treatment of acute pancreatitis in early phase

Treatment groups

200 Participants
are divided into 2 treatment groups